Skip to main content

Advertisement

Log in

Anti-obesity activity of Yamabushitake (Hericium erinaceus) powder in ovariectomized mice, and its potentially active compounds

  • Original Paper
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

Hericium erinaceus (H. erinaceus) improves the symptoms of menopause. In this study, using ovariectomized mice as a model of menopause, we investigated the anti-obesity effect of this mushroom in menopause. Mice fed diets containing H. erinaceus powder showed significant decreases in the amounts of fat tissue, plasma levels of total cholesterol, and leptin. To determine the mechanism, groups of mice were respectively fed a diet containing H. erinaceus powder, a diet containing ethanol extract of H. erinaceus, and a diet containing a residue of the extract. As a result, H. erinaceus powder was found to increase fecal lipid levels in excreted matter. Further in vitro investigation showed that ethanol extract inhibited the activity of lipase, and four lipase-inhibitory compounds were isolated from the extract: hericenone C, hericenone D, hericenone F, and hericenone G. In short, we suggest that H. erinaceus has an anti-obesity effect during menopause because it decreases the ability to absorb lipids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Miquel J, Ramirez-Bosca A, Ramirez-Bosca JV, Alperi JD (2006) Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants. Arch Gerontol Geriatr 42:289–306

    Article  CAS  PubMed  Google Scholar 

  2. Kronenberg F (1994) Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol 29:319–336

    Article  CAS  PubMed  Google Scholar 

  3. Genazzani AR, Gambacciani M (2001) HRT in the third millennium. Maturitas 38:S49–S55

    Article  PubMed  Google Scholar 

  4. Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S (2007) Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiol Drug Saf 16:17–27

    Article  PubMed  Google Scholar 

  5. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333

    Article  CAS  PubMed  Google Scholar 

  6. Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, Bernal-Mizrachi C, Muslin AJ, Kastan MB, Semenkovich CF (2006) ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4:377–389

    Article  CAS  PubMed  Google Scholar 

  7. Bays H, Blonde L, Rosenson R (2006) Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Expert Rev Cardiovasc Ther 4:871–895

    Article  PubMed  Google Scholar 

  8. Mazzucotelli A, Langin D (2006) Fatty acid mobilization and their use in adipose tissue. J Soc Biol 200:83–91

    Article  CAS  PubMed  Google Scholar 

  9. Reeves AF, Rees JM, Schiff M, Hujoel P (2006) Total body weight and waist circumference associated with chronic periodontitis among adolescents in the United States. Arch Pediatr Adolesc Med 160:894–899

    Article  PubMed  Google Scholar 

  10. Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, Suzuki Y, Ohmori K, Nishino Y, Tsuji I (2005) Obesity and risk of cancer in Japan. Int J Cancer 113:148–157

    Article  CAS  PubMed  Google Scholar 

  11. Lee JS, Hong EK (2010) Hericium erinaceus enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells. Cancer Lett 297:144–154

    Article  CAS  PubMed  Google Scholar 

  12. Wang JC, Hu SH, Su CH, Lee TM (2001) Antitumor and immunoenhancing activities of polysaccharide from culture broth of Hericium spp. Kaohsiung J Med Sci 17:461–467

    CAS  PubMed  Google Scholar 

  13. Okamoto K, Shimada A, Shirai R, Sakamoto H, Yoshida S, Ojima F, Ishiguro Y, Sakai T, Kawagishi H (1993) Antimicrobial chlorinated orcinol derivatives from mycelia of Hericium erinaceum. Phytochemistry 34:1445–1446

    Article  CAS  Google Scholar 

  14. Mau JL, Lin HC, Song SF (2002) Antioxidant properties of several specialty mushrooms. Food Res Int 35:519–526

    Article  CAS  Google Scholar 

  15. Li YR, Zhang GQ, Ng TB, Wang HX (2010) A novel lectin with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from dried fruiting bodies of the monkey head mushroom Hericium erinaceum. J Biomed Biotechnol 2010:71615

    Google Scholar 

  16. Mori K, Obara Y, Hirota M, Azumi Y, Kinugasa S, Inatomi S, Nakahata N (2008) Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol Pharm Bull 31:1727–1732

    Article  CAS  PubMed  Google Scholar 

  17. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T (2009) Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 23:367–372

    Article  CAS  PubMed  Google Scholar 

  18. Nagano M, Shimizu K, Kondo R, Hayashi C, Sato D, Kitagawa K, Ohnuki K (2010) Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res 31:231–237

    Article  CAS  PubMed  Google Scholar 

  19. Hiwatashi K, Kosaka Y, Suzuki N, Hata K, Mukaiyama T, Sakamoto K, Shirakawa H, Komai M (2010) Yamabushitake mushroom (Hericium erinaceus) improved lipid metabolism in mice fed a high-fat diet. Biosci Biotechnol Biochem 74:1447–1451

    Article  CAS  PubMed  Google Scholar 

  20. Ministry of Health, Labour and Welfare (2008) Annual Health, Labour and Welfare Report 2007–2008. http://www.mhlw.go.jp/english/wp/wp-hw2/index.html. Accessed 22 Dec 2014

  21. Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509

    CAS  PubMed  Google Scholar 

  22. Mizutani T, Inatomi S, Inazu A, Kawahara E (2010) Hypolipidemic effect of Pleurotus eryngii extract in fat-loaded mice. J Nutr Sci Vitaminol 56:48–53

    Article  CAS  PubMed  Google Scholar 

  23. Kawagishi H, Ando M, Sakamoto H, Yoshida S, Ojima F, Ishiguro Y, Ukai N, Furukawa S (1991) Hericenones C, D and E, stimulators of nerve growth factor (NGF)-synthesis, from the mushroom Hericium erinaceum. Tetrahedron Lett 32:4561–4564

    Article  CAS  Google Scholar 

  24. Kawagishi H, Ando M, Shinba K, Sakamoto H, Yoshida S, Ojima F, Ishiguro Y, Ukai N, Furukawa S (1993) Chromans, hericenones F, G and H from the mushroom Hericium erinaceum. Phytochemistry 32:175–178

    Article  Google Scholar 

  25. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tornqvist H, Hauner H (1996) Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 45:1435–1438

    Article  CAS  PubMed  Google Scholar 

  26. Ludgero-Correia A Jr, Aguila MB, Mandarim-de-Lacerda CA, Faria TS (2012) Effects of high-fat diet on plasma lipids, adiposity, and inflammatory markers in ovariectomized C57BL/6 mice. Nutrition 28:316–323

    Article  CAS  PubMed  Google Scholar 

  27. Wang HB, Tranguch S, Xie HR, Hanley G, Das SK, Dey SK (2005) Variation in commercial rodent diets induces disparate molecular and physiological changes in the mouse uterus. Proc Natl Acad Sci USA 102:9960–9965

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Ros E (2000) Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk. Atherosclerosis 151:357–379

    Article  CAS  PubMed  Google Scholar 

  29. Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M (1998) Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 352:167–172

    Article  CAS  PubMed  Google Scholar 

  30. Gariepy G, Nitka D, Schmitz N (2010) The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes 34:407–419

    Article  CAS  Google Scholar 

  31. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG (2010) Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67:220–229

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to Dr. Yasuko Tanaka, the Center of Advanced Instrumental Analysis, Kyushu University for the HI-EIMS measurements. We appreciate the technical support provided by the Research Support Center, Graduate School of Medical Sciences, Kyushu University. The fruiting body was received from Aso Biotech Co. (Kumamoto, Japan) for free.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kuniyoshi Shimizu.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

E. Hiraki and S. Furuta equally contributed to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

11418_2017_1075_MOESM1_ESM.tiff

Changes in body fat in study 2. Statistical differences between the four groups were assessed with the Tukey–Kramer test. n = 6. Mean ± SEM (TIFF 1521 kb)

Supplementary material 2 (DOCX 127 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hiraki, E., Furuta, S., Kuwahara, R. et al. Anti-obesity activity of Yamabushitake (Hericium erinaceus) powder in ovariectomized mice, and its potentially active compounds. J Nat Med 71, 482–491 (2017). https://doi.org/10.1007/s11418-017-1075-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-017-1075-8

Keywords

Navigation